Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-05

FDA Approved: GALZIN — Supplemental Application (Eton Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for GALZIN (zinc acetate) by Eton Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GALZIN (Zinc acetate)

Snippet

SUPPL AP for GALZIN (ZINC ACETATE)